Health, Wellness & Beauty

AMSTERDAM – October 28, 2026 -- The Philips Lumea 9900 Pro, which Philips describes as the first at-home IPL device with audio feedback and motion guidance that talks to you, is now on sale at a recommended retail price of EUR 799.99. The launch arrives alongside three beauty technology trends outlined by a dermatologist, a foresight analyst and a wellness founder.

Shoppers expect guidance, not just information

Mintel research cited by Philips shows that 62% of U.S. beauty and personal care buyers are interested in hyper-personalized products. Alice Crossley, Principal Strategic Foresight Analyst at The Future Laboratory, says consumers now expect beauty technology to respond in real time and explain why it recommends a given step. Brands that turn complex science into practical, personal advice will shape the next wave of innovation, she says.

United States – October 28, 2026 -- Solid Biosciences has dosed 40 participants with its Duchenne gene therapy SGT-003 and reported positive interim safety and biomarker data from the ongoing Phase 1/2 INSPIRE DUCHENNE trial. The company presented the update at the 2026 MDA Clinical & Scientific Conference.

The therapy delivers a shortened dystrophin protein

SGT-003 delivers microdystrophin, a shortened version of dystrophin designed to help support and protect muscle cells during movement. The data show robust microdystrophin expression. They also show restoration of beta-sarcoglycan and nNOS, proteins that normally work with dystrophin in the dystrophin-associated protein complex (DAPC), the muscle cell support system.

United States – October 27, 2026 -- Solid Biosciences has expanded its INSPIRE DUCHENNE gene therapy trial to 43 participants and now accepts children aged 4 to under 12, up from the previous range of 4 to under 8.

Three participants dosed with no serious adverse events

INSPIRE DUCHENNE is a first-in-human, multicenter, Phase 1/2 open-label study. It tests the safety, tolerability and efficacy of a single intravenous infusion of SGT-003, a next-generation AAV gene therapy candidate, in ambulant boys with Duchenne.

Three participants have been dosed so far. According to Solid, SGT-003 has been well tolerated to date, and no serious adverse events have been reported. The company plans to share safety, expression and biomarker data from these first three patients, along with a trial update, in the first quarter of 2025.

Global – October 27, 2026 -- Fifty-three boys with Duchenne muscular dystrophy have now received the investigational gene therapy SGT-003, and a Phase 3 trial is already enrolling patients in Australia and Canada. Solid Biosciences shared the update in a letter to the Duchenne community as the annual Parent Project Muscular Dystrophy (PPMD) conference got under way.

The Phase 1/2 trial spans ages 0 to 10

The count comes from the Phase 1/2 INSPIRE DUCHENNE trial and reflects a June 22, 2026, enrollment cutoff. Participants range from 0 to 10 years old. One of them is a 6-month-old boy who, to the company's knowledge, is the youngest child ever dosed with a microdystrophin gene therapy.

Solid reports no cases of four serious safety conditions

The company describes SGT-003 as generally well tolerated. It reports no observed cases of drug-induced liver injury, myocarditis, thrombotic microangiopathy or atypical hemolytic uremic syndrome.

United States – October 27, 2026 -- Cannabis sold in legal-sale states in 2023 contains 25-90% THC, compared with roughly 2-4% before 1990, so parents who tried it in their youth may be thinking of a very different drug. Mothers Against Drunk Driving (MADD) is urging parents to update their conversations with teens through its Power of Parents program.

Potency has jumped by more than 100 times

MADD says the difference can be over 100-fold. Its comparison: if beer had strengthened the same way, one beer today would equal more than 20 beers in 1990. Beer potency, by contrast, has changed very little because of strong regulation.

New York – October 22, 2026 -- RVO Health's Script Portability technology lets consumers see their pharmacy options, with cost and convenience details, before a prescription is sent. The company has now received its third U.S. patent covering the capability.

A third patent joins two earlier ones in the Siegel family

The U.S. Patent and Trademark Office granted U.S. Patent No. 12,580,060 B2. The earlier patents in the same family are No. 11,651,843 and No. 12,119,098.

Orange County – October 20, 2026 -- Older LGBTQ+ adults in Orange County can get routine primary care at the Radiant Health Centers LGBTQ+ clinic, which offers preventive screenings and chronic disease management in a stigma-free setting.

Regular checkups catch health problems before they progress

Routine visits let providers identify potential health issues early, when timely intervention can improve long-term outcomes for older patients. Providers can also track changes in a patient's health, recommend appropriate screenings and adjust treatment plans as needed.

The appointments also give LGBTQ+ seniors a chance to raise personal health concerns that may be affecting their well-being.

Orange County – October 20, 2026 -- Routine checkups, screenings and wellness exams can help LGBTQ+ adults stay independent as they age, according to Radiant Health Centers, an LGBTQ+ medical clinic serving Orange County.

Screenings help providers catch concerns before they worsen

Regular wellness exams, recommended screenings and personalized health assessments let providers identify potential problems before they become more serious. Patients who keep up with preventive visits can manage their health more effectively and maintain a better quality of life with age.

Regular visits shape a care plan around each patient

Health needs change over time, and preventive appointments give providers a fuller picture of a patient's health history. That allows them to build a care plan around the individual's specific needs and life experiences.

Irvine – October 20, 2026 -- Patients heading into a first primary care visit in Orange County can prepare with three steps: gather health records, write down questions and know what the appointment includes, according to Radiant Health Centers.

The clinic has served LGBTQ+ patients in Irvine, Santa Ana and across Orange County for more than 40 years. It describes its primary care as inclusive and judgment-free, with patients able to discuss their health openly.

Bring your health history to the exam room

Collect records on past medical conditions, surgeries and allergies, plus any recent test results. Add a list of every medication and supplement you take. The clinic says this information helps a provider understand your history and make informed care recommendations.

Orange County – October 20, 2026 -- Radiant Health Centers is running community health education programs across Orange County that cover nutrition, reproductive health, HIV and STI prevention, and chronic disease management. The programs are open to people of all backgrounds, including the LGBTQ+ community.

Programs teach patients to evaluate online health information

Health information is easy to find online, but patients may not know how to judge it or apply it to their own situation. The clinic's education programs cover risk factors for certain conditions, ways to prevent illness, symptoms of common diseases and available treatment options.

Daily habits are part of the curriculum

Sessions address nutrition, physical activity, sleep and stress management. The aim is to help patients see how these factors connect and to build practical habits that affect both physical and mental well-being.